Phosphate-Triggered E. Coli Autoinduction for High Recombinant Protein Yield

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for heterologous protein expression in E. coli, such as those using BL21(DE3) strains, suffer from low biomass and protein levels, heterogeneous induction, and toxic effects from lactose-based inducers, leading to inefficient protein production across various culture systems, including instrumented bioreactors.

Innovation Solution

A method utilizing a phoB regulated promoter induced by phosphate depletion in engineered E. coli strains, combined with optimized media containing yeast extract, casamino acids, and specific nutrients, enables tightly controlled autoinduction of protein expression, suitable for small to large culture volumes, minimizing acetate production and maximizing protein yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If lactose-based inducers are used for protein expression, then induction occurs after glucose depletion, but heterogeneous induction and acetic acid accumulation occur leading to toxic effects

Engineering Contradiction:
Improveprotein expression levelVSAvoidtoxic effects from acetic acid
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the induction mechanism by using a phosphate-responsive promoter (PhoA) instead of lactose-based induction. This parameter change in the induction system eliminates acetic acid accumulation while maintaining high protein expression levels, as the phosphate limitation condition triggers uniform induction without the metabolic side effects of lactose utilization.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts the harmful effect of phosphate limitation (which normally slows growth) into a beneficial induction signal. By designing the PhoA promoter to respond to phosphate starvation, the condition that would normally be detrimental is transformed into a controlled trigger for uniform protein expression without acetic acid production.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Ease of operation

If standard auto-induction protocols are used, then manual additions are removed, but biomass and protein levels remain relatively low

Engineering Contradiction:
Improveprotocol simplicityVSAvoidbiomass and protein levels
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The patent modifies the media composition parameters by using defined minimal media with controlled phosphate levels instead of complex auto-induction media. This parameter change enables both ease of operation and high productivity, as the defined media composition with limited phosphate automatically triggers uniform induction while supporting high cell density growth and protein expression.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If BL21 and its derivatives are used for expression, then heterologous protein production is achieved, but heterogeneous induction occurs resulting from lactose-based inducers

Engineering Contradiction:
Improveheterologous protein productionVSAvoidinduction homogeneity
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent changes the induction parameter from lactose-based to phosphate-responsive induction using the PhoA promoter. This parameter change achieves homogeneous induction across the culture population while maintaining high heterologous protein production in BL21 cells, eliminating the heterogeneous induction problem associated with lactose-based systems.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If phosphate depletion is used to induce expression, then tightly controlled autoinduction is achieved, but expression occurs during stationary phase which may seem counterintuitive

Engineering Contradiction:
Improveexpression controlVSAvoidinduction timing control
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs a self-service induction mechanism where the PhoA promoter automatically responds to phosphate depletion in the media. The system self-regulates the induction timing based on the physiological state of the culture, eliminating the need for external control mechanisms while achieving reliable and homogeneous protein expression during stationary phase.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach achieves high-level protein expression, reaching up to 55% of total cellular protein content, with cell densities of 10 gCDW/L and protein titers of 2.7 g/L, adaptable to microtiter plates to large bioreactors, and validated with diverse heterologous proteins.

Implementation Method 1

a promoter that is induced by phosphate depletion, where protein expression is induced at the entry into stationary phase

Methodology Applied
Scientific EffectPhosphate depletion induction:

Data Source

PatentUS12577572B2Compositions, systems, and methods for high level expression of recombinant protein
Publication Date: 2026.03.17 DUKE UNIV
  • US12577572B2 patent drawing
  • US12577572B2 patent drawing
  • US12577572B2 patent drawing

AI summary

Improved production of recombinant proteins in E. coli, reliant on tightly controlled autoinduction, triggered by phosphate depletion in stationary phase. The process also provides an optimized autoinduction media, enabling routine batch production at various culture volumes where cells densities routinely reach ˜5-7 g cell dry weight per liter and offer protein titers above 2 g/L. The methodology has been validated with a set of diverse heterologous proteins and is of general use for the facile optimization of routine protein expression from high throughput screens to fed-batch fermentation.